<DOC>
	<DOCNO>NCT02592057</DOCNO>
	<brief_summary>This study evaluate safety efficacy sofosbuvir ( SOF ) -based regimen administer per approve prescribe information adult chronic hepatitis C virus ( HCV ) infection treat routine clinical practice India .</brief_summary>
	<brief_title>Safety Efficacy Sofosbuvir-based Regimens Clinical Practice Treatment Chronic Hepatitis C Virus Infection India</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>HCVinfected patient live India Treatment SOFbased regimen determine patient 's treat physician per approve prescribing information . Patients provide write sign informed consent prior initiation treatment require . Concurrent participation HCV clinical trial ( except trial test investigational medicinal product ) Patients present risk able follow ( eg , patient plan move leave country foreseeable future )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>